Search results
Results From The WOW.Com Content Network
Muscular dystrophies (MD) are a genetically and clinically heterogeneous group of rare neuromuscular diseases that cause progressive weakness and breakdown of skeletal muscles over time. [1] The disorders differ as to which muscles are primarily affected, the degree of weakness, how fast they worsen, and when symptoms begin. [ 1 ]
Mueller–Weiss syndrome, also known as Mueller–Weiss disease, is a rare [2] idiopathic degenerative disease of the adult navicular bone characterized by progressive collapse and fragmentation, leading to mid- and hindfoot pain and deformity. [3] [1] It is most commonly seen in females, ages 40–60. [4]
The popliteal artery entrapment syndrome (PAES) is an uncommon pathology that occurs when the popliteal artery is compressed by the surrounding popliteal fossa myofascial structures. [1] This results in claudication and chronic leg ischemia .
Central Maine Healthcare Rumford: Oxford: Yes Active: Saint Joseph Hospital Covenant Health Systems: Bangor Penobscot Yes Active: Saint Mary's Regional Medical Center: Covenant Health Systems Lewiston Androscoggin Yes 1888–present Active: Spring Harbor Hospital: MaineHealth Westbrook: Cumberland No Active - Behavioral health hospital ...
[99] [100] In 2007, researchers did the world's first clinical (viral-mediated) gene therapy trial for Duchenne MD. [ 101 ] Biostrophin is a delivery vector for gene therapy in the treatment of Duchenne muscular dystrophy and Becker muscular dystrophy .
Maine Medical Center is a teaching hospital, with an affiliation with the University of Southern Maine, Saint Joseph's College, Tufts University and Dartmouth College. As a part of its mission, MMC is also a leader in biomedical research, through its Maine Medical Center Research Institute, ongoing clinical trials, and translational research.
Facioscapulohumeral muscular dystrophy (FSHD) is a type of muscular dystrophy, a group of heritable diseases that cause degeneration of muscle and progressive weakness. Per the name, FSHD tends to sequentially weaken the muscles of the face, those that position the scapula, and those overlying the humerus bone of the upper arm.
Isolated case reports of myotonia had been published previously, including reports by Frederick Eustace Batten and Hans Curschmann, and type 1 myotonic dystrophy is therefore sometimes known as Curschmann-Batten-Steinert syndrome. [35] The underlying cause of type 1 myotonic dystrophy was determined in 1992. [2]